Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma.

Raz DJ, Ray MR, Kim JY, He B, Taron M, Skrzypski M, Segal M, Gandara DR, Rosell R, Jablons DM.

Clin Cancer Res. 2008 Sep 1;14(17):5565-70. doi: 10.1158/1078-0432.CCR-08-0544.

PMID:
18765549
[PubMed - indexed for MEDLINE]
Free Article
2.

Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.

Iwakiri S, Mino N, Takahashi T, Sonobe M, Nagai S, Okubo K, Wada H, Date H, Miyahara R.

Cancer. 2009 Jun 1;115(11):2580-93. doi: 10.1002/cncr.24281.

PMID:
19309748
[PubMed - indexed for MEDLINE]
Free Article
3.

Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.

Seike M, Yanaihara N, Bowman ED, Zanetti KA, Budhu A, Kumamoto K, Mechanic LE, Matsumoto S, Yokota J, Shibata T, Sugimura H, Gemma A, Kudoh S, Wang XW, Harris CC.

J Natl Cancer Inst. 2007 Aug 15;99(16):1257-69. Epub 2007 Aug 8.

PMID:
17686824
[PubMed - indexed for MEDLINE]
Free Article
4.

A prognostic test for adenocarcinoma of the lung from gene expression profiling data.

Gordon GJ, Richards WG, Sugarbaker DJ, Jaklitsch MT, Bueno R.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):905-10.

PMID:
14504202
[PubMed - indexed for MEDLINE]
Free Article
5.

Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma.

Yamashita S, Chujo M, Tokuishi K, Anami K, Miyawaki M, Yamamoto S, Kawahara K.

J Thorac Cardiovasc Surg. 2009 Dec;138(6):1303-8. doi: 10.1016/j.jtcvs.2009.08.003. Epub 2009 Oct 9.

PMID:
19818968
[PubMed - indexed for MEDLINE]
6.

Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.

Park JY, Lee WK, Jung DK, Choi JE, Park TI, Lee EB, Cho S, Park JY, Cha SI, Kim CH, Kam S, Jung TH, Jheon S.

Clin Cancer Res. 2009 Mar 1;15(5):1794-800. doi: 10.1158/1078-0432.CCR-08-1770. Epub 2009 Feb 24.

PMID:
19240174
[PubMed - indexed for MEDLINE]
Free Article
7.

Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.

Metzger R, Vallbohmer D, Müller-Tidow C, Higashi H, Bollschweiler E, Warnecke-Eberz U, Brabender J, Baldus SE, Xi H, Berdel WE, Serve H, Hoelscher AH, Schneider PM.

Anticancer Res. 2009 Apr;29(4):1157-62.

PMID:
19414359
[PubMed - indexed for MEDLINE]
Free Article
8.

Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.

Endoh H, Tomida S, Yatabe Y, Konishi H, Osada H, Tajima K, Kuwano H, Takahashi T, Mitsudomi T.

J Clin Oncol. 2004 Mar 1;22(5):811-9.

PMID:
14990636
[PubMed - indexed for MEDLINE]
9.

Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).

Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, Tan L, Agasthian T, Koong HN, Tam J, Tan C, Caleb M, Chang A, Ng A, Tan P.

J Thorac Oncol. 2009 Jan;4(1):12-21. doi: 10.1097/JTO.0b013e3181913e28.

PMID:
19096301
[PubMed - indexed for MEDLINE]
10.

KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer.

Corson TW, Zhu CQ, Lau SK, Shepherd FA, Tsao MS, Gallie BL.

Clin Cancer Res. 2007 Jun 1;13(11):3229-34.

PMID:
17545527
[PubMed - indexed for MEDLINE]
Free Article
11.

A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma.

Mino N, Miyahara R, Nakayama E, Takahashi T, Takahashi A, Iwakiri S, Sonobe M, Okubo K, Hirata T, Sehara A, Date H.

J Surg Oncol. 2009 Sep 1;100(3):267-72. doi: 10.1002/jso.21313.

PMID:
19544357
[PubMed - indexed for MEDLINE]
12.

Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.

Raponi M, Zhang Y, Yu J, Chen G, Lee G, Taylor JM, Macdonald J, Thomas D, Moskaluk C, Wang Y, Beer DG.

Cancer Res. 2006 Aug 1;66(15):7466-72.

PMID:
16885343
[PubMed - indexed for MEDLINE]
Free Article
13.

Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.

Mizuno T, Ishii G, Nagai K, Yoshida J, Nishimura M, Mochizuki T, Kawai O, Hasebe T, Ochiai A.

Lung Cancer. 2008 Dec;62(3):302-8. doi: 10.1016/j.lungcan.2008.03.032. Epub 2008 May 19.

PMID:
18486987
[PubMed - indexed for MEDLINE]
14.

Gene-expression profiles predict survival of patients with lung adenocarcinoma.

Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, Hanash S.

Nat Med. 2002 Aug;8(8):816-24. Epub 2002 Jul 15.

PMID:
12118244
[PubMed - indexed for MEDLINE]
15.

The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain.

Grinberg-Rashi H, Ofek E, Perelman M, Skarda J, Yaron P, Hajdúch M, Jacob-Hirsch J, Amariglio N, Krupsky M, Simansky DA, Ram Z, Pfeffer R, Galernter I, Steinberg DM, Ben-Dov I, Rechavi G, Izraeli S.

Clin Cancer Res. 2009 Mar 1;15(5):1755-61. doi: 10.1158/1078-0432.CCR-08-2124. Epub 2009 Feb 3.

PMID:
19190132
[PubMed - indexed for MEDLINE]
Free Article
16.

Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.

Skrzypski M, Jassem E, Taron M, Sanchez JJ, Mendez P, Rzyman W, Gulida G, Raz D, Jablons D, Provencio M, Massuti B, Chaib I, Perez-Roca L, Jassem J, Rosell R.

Clin Cancer Res. 2008 Aug 1;14(15):4794-9. doi: 10.1158/1078-0432.CCR-08-0576.

PMID:
18676750
[PubMed - indexed for MEDLINE]
Free Article
17.

Gene expression signature predicts recurrence in lung adenocarcinoma.

Larsen JE, Pavey SJ, Passmore LH, Bowman RV, Hayward NK, Fong KM.

Clin Cancer Res. 2007 May 15;13(10):2946-54.

PMID:
17504995
[PubMed - indexed for MEDLINE]
Free Article
18.

Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.

Higashiyama M, Oda K, Okami J, Maeda J, Kodama K, Takenaka A, Nakayama T, Yoneda G.

Eur J Cardiothorac Surg. 2009 Feb;35(2):337-42. doi: 10.1016/j.ejcts.2008.10.013. Epub 2008 Nov 28.

PMID:
19041255
[PubMed - indexed for MEDLINE]
19.

High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.

Anagnostou VK, Bepler G, Syrigos KN, Tanoue L, Gettinger S, Homer RJ, Boffa D, Detterbeck F, Rimm DL.

Clin Cancer Res. 2009 Jun 15;15(12):4157-64. doi: 10.1158/1078-0432.CCR-09-0099. Epub 2009 Jun 9.

PMID:
19509151
[PubMed - indexed for MEDLINE]
Free Article
20.

An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.

Roepman P, Jassem J, Smit EF, Muley T, Niklinski J, van de Velde T, Witteveen AT, Rzyman W, Floore A, Burgers S, Giaccone G, Meister M, Dienemann H, Skrzypski M, Kozlowski M, Mooi WJ, van Zandwijk N.

Clin Cancer Res. 2009 Jan 1;15(1):284-90. doi: 10.1158/1078-0432.CCR-08-1258.

PMID:
19118056
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk